Rambus Other Non-Current Liabilities increased by 1.1% to $5.02M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 50.1%, from $10.08M to $5.02M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows a downward trend with a -6.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.06M | $17.83M | $28.48M | $30.16M | $42.71M | $39.08M | $46.65M | $45.98M | $45.16M | $34.98M | $25.80M | $18.96M | $14.24M | $12.31M | $5.13M | $10.08M | $4.31M | $3.89M | $4.97M | $5.02M |
| QoQ Change | — | +482.5% | +59.7% | +5.9% | +41.6% | -8.5% | +19.4% | -1.4% | -1.8% | -22.5% | -26.2% | -26.5% | -24.9% | -13.5% | -58.4% | +96.5% | -57.2% | -9.7% | +27.6% | +1.1% |
| YoY Change | — | — | — | — | >999% | +119.2% | +63.8% | +52.5% | +5.7% | -10.5% | -44.7% | -58.8% | -68.5% | -64.8% | -80.1% | -46.9% | -69.7% | -68.4% | -3.1% | -50.1% |